Imhof; Beat A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Imhof; Beat A..The latest application filed is for "modulation of srpx2-mediated angiogenesis".

Company Profile

1.8.14

Imhof; Beat A. - Geneva CH
Imhof; Beat A. - Conches CH
Imhof, Beat A. - Conches GE CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Monoclonal Olfml-3 antibodies and uses thereof Grant 10,808,026 - Imhof , et al. October 20, 2	2020-10-20
Modulation Of Srpx2-mediated Angiogenesis App 20180214546 - IMHOF; Beat A. ; et al.	2018-08-02
Methods And Compositions For Modulation Of Olfml3 Mediated Angiogenesis App 20160333084 - IMHOF; Beat A. ; et al.	2016-11-17
Methods And Compositions For Modulation Of Olfml3 Mediated Angiogenesis App 20150299306 - IMHOF; Beat A. ; et al.	2015-10-22
Methods and compositions for modulation of Olfml3 mediated angiogenisis Grant 9,096,662 - Imhof , et al. August 4, 2	2015-08-04
Monoclonal Olfml-3 Antibodies And Uses Thereof App 20150098947 - IMHOF; Beat A. ; et al.	2015-04-09
Methods And Compositions For Modulation Of Olfml3 Mediated Angiogenesis App 20140199237 - IMHOF; Beat A. ; et al.	2014-07-17
Methods and compositions for modulation of Olfml3 mediated angiogenesis Grant 8,663,637 - Imhof , et al. March 4, 2	2014-03-04
Modulation Of Srpx2-mediated Angiogenesis App 20130084296 - IMHOF; Beat A. ; et al.	2013-04-04
Methods And Compositions For Modulation Of Olfml3 Mediated Angiogenesis App 20130034493 - Imhof; Beat A. ; et al.	2013-02-07
Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer Grant 8,093,010 - Imhof , et al. January 10, 2	2012-01-10
Modulation Of Olfml-3 Mediated Angiogenesis App 20110287088 - Imhof; Beat A. ; et al.	2011-11-24
Modulation Of Srpx2-mediated Angiogenesis App 20110052677 - Imhof; Beat A. ; et al.	2011-03-03
Angiogenesis Inhibiting Molecules, Their Selection, Production and Their Use in the Treatment of Cancer App 20100279307 - IMHOF; BEAT A. ; et al.	2010-11-04
Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer Grant 7,790,863 - Imhof , et al. September 7, 2	2010-09-07
Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer Grant 7,642,341 - Imhof , et al. January 5, 2	2010-01-05
Angiogenesis Inhibiting Molecules And Their Use In The Treatment And Diagnosis Of Cancer App 20070202110 - Imhof; Beat A. ; et al.	2007-08-30
Basolateral sorting signal and inhibitors thereof Grant 7,033,794 - Wehrle-Haller , et al. April 25, 2	2006-04-25
Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer App 20050136060 - Imhof, Beat A. ; et al.	2005-06-23
Basolateral sorting signal and inhibitors thereof App 20030237101 - Wehrle-Haller, Bernhard M. ; et al.	2003-12-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.